Literature DB >> 19172108

Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.

Xuefeng Liu1, Xianwei Dai, Bin Wu.   

Abstract

OBJECTIVES: To investigate the effect of 5-Aza-CdR on methylation and expression of RASSF1A gene in the human bladder cancer BIU87 cell line.
METHODS: Cultured BIU87 cells were treated with increasing concentrations (0.1, 0.5, 1.0, 5.0 micromol/l) of 5-Aza-CdR. MTT was used to detect the proliferation of BIU87 cells. The methylation status and expression level of RASSF1A gene in BIU87 cells were analyzed by methylation-specific polymerase chain reaction and RT-PCR before and after treatment with 5-Aza-CdR. Meanwhile, Western blot was used to detect the changes of RASSF1A protein.
RESULTS: In this study we found that the growth velocity of the BIU87 cell line was suppressed to various degrees after having been treated with different concentrations of 5-Aza-CdR, and the survival rate decreased with increasing 5- Aza-CdR concentrations. Besides, the methylation status of RASSF1A was obviously reversed and mRNA was re-expressed after treatment with 5-Aza-CdR. Expression of RASSF1A protein increased with increasing 5-Aza-CdR concentrations.
CONCLUSIONS: Our results suggest that the tumor-suppressive effect of 5-Aza-CdR may result from reactivation of silenced RASSF1A through a demethylation function. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172108     DOI: 10.1159/000176036

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  5-Aza-2''-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene.

Authors:  Ru Liu; Xiao-Huan Zhang; Kun Zhang; Wei Li; Wen-Jun Wang; Di-Xian Luo; Ling Gao
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.

Authors:  Surbhi Jain; Lijia Xie; Batbold Boldbaatar; Selena Y Lin; James P Hamilton; Stephen J Meltzer; Shun-Hua Chen; Chi-Tan Hu; Timothy M Block; Wei Song; Ying-Hsiu Su
Journal:  Hepatol Res       Date:  2014-12-09       Impact factor: 4.288

Review 3.  Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.

Authors:  Iris Lodewijk; Sandra P Nunes; Rui Henrique; Carmen Jerónimo; Marta Dueñas; Jesús M Paramio
Journal:  Clin Epigenetics       Date:  2021-03-24       Impact factor: 6.551

Review 4.  DNA Methylation as a Therapeutic Target for Bladder Cancer.

Authors:  Sandra P Nunes; Rui Henrique; Carmen Jerónimo; Jesús M Paramio
Journal:  Cells       Date:  2020-08-07       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.